| CCND3 rs2479717 genotype | |||
---|---|---|---|---|
 | AA | AT | TT | Missing |
Stage | Â | Â | Â | Â |
   1 | 1,193 (54.5%) | 808 (36.9%) | 142 (6.5%) | 48 (2.2%) |
   2 | 1,031 (52.0%) | 753 (38.0%) | 145 (7.3%) | 54 (2.7%) |
   3 or 4 | 90 (46.4%) | 82 (42.3%) | 17 (8.8%) | 5 (2.6%) |
   Missing | 60 (58.8%) | 31 (30.4%) | 9 (8.8%) | 2 (2.0%) |
Grade | Â | Â | Â | Â |
   1 | 484 (55.4%) | 314 (35.9%) | 60 (6.9%) | 16 (1.8%) |
   2 | 889 (52.7%) | 658 (39.0%) | 104 (6.2%) | 36 (2.1%) |
   3 | 533 (52.3%) | 375 (36.8%) | 86 (8.4%) | 26 (2.5%) |
   Missing | 468 (52.5%) | 327 (36.7%) | 63 (7.1%) | 34 (3.8%) |
Estrogen receptor status | Â | Â | Â | Â |
   Positive | 1,089 (55.1%) | 717 (36.3%) | 130 (6.6%) | 39 (2.0%) |
   Negative | 320 (49.3%) | 262 (40.4%) | 53 (8.2%) | 14 (2.2%) |
   Missing | 965 (52.3%) | 695 (37.6%) | 130 (7.0%) | 56 (3.0%) |